Interestingly, early onset T2D and MODY-associated TGM2 mutants have altered enzymatic activities, such as reduced transamidation and kinase activity that impact in glucose-stimulated insulin release (28). The gene discussed is INS; the disease is type 2 diabetes mellitus.